F.I.R.S.T Trademark

Trademark Overview

On Friday, July 21, 2023, a trademark application was filed for F.I.R.S.T with the United States Patent and Trademark Office. The USPTO has given the F.I.R.S.T trademark a serial number of 98095865. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Friday, January 31, 2025. This trademark is owned by BioInvent International AB. The F.I.R.S.T trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; pharmaceutical product development; consultancy pertaining to pharmacology; research and development services in the field of antibody technology
f.i.r.s.t

General Information

Serial Number98095865
Word MarkF.I.R.S.T
Filing DateFriday, July 21, 2023
Status651 - SUSPENSION INQUIRY - MAILED
Status DateFriday, January 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkFIRST 1st
Goods and ServicesScientific research and development; pharmaceutical product development; consultancy pertaining to pharmacology; research and development services in the field of antibody technology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioInvent International AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLund SE-22370
SE

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2024SUSPENSION LETTER WRITTEN
Tuesday, March 26, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Wednesday, April 30, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, April 30, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 21, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 31, 2025INQUIRY TO SUSPENSION E-MAILED
Friday, January 31, 2025SUSPENSION INQUIRY WRITTEN
Friday, January 31, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Related Keywords

development research services field technology pharmacology antibody consultancy pharmaceutical product